Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 7 of 10
Neurogene Inc.
Shares:27.9K
Value:$327.0K
ESTABLISHMENT LABS HOLDINGS INC.
Shares:8.0K
Value:$326.4K
Ventyx Biosciences, Inc.
Shares:281.6K
Value:$323.8K
G5212E105
Shares:30.0K
Value:$321.6K
Dyne Therapeutics, Inc.
Shares:30.1K
Value:$314.8K
OmniAb, Inc.
Shares:126.1K
Value:$302.7K
NORDSTROM INC
Shares:12.0K
Value:$293.4K
Kymera Therapeutics, Inc.
Shares:10.0K
Value:$273.7K
Celldex Therapeutics, Inc.
Shares:14.6K
Value:$265.0K
Iron Horse Acquisitions Corp.
Shares:25.0K
Value:$262.0K
Voyager Therapeutics, Inc.
Shares:75.5K
Value:$255.3K
Nurix Therapeutics, Inc.
Shares:21.2K
Value:$251.9K
Gossamer Bio, Inc.
Shares:227.2K
Value:$250.0K
TherapeuticsMD, Inc.
Shares:270.2K
Value:$249.9K
Spyre Therapeutics, Inc.
Shares:15.0K
Value:$242.6K
Day One Biopharmaceuticals, Inc.
Shares:28.0K
Value:$222.2K
Ascendis Pharma A/S
Shares:1.4K
Value:$218.5K
M8001Q126
Shares:80.1K
Value:$217.0K
EXACT SCIENCES CORP
Shares:5.0K
Value:$216.4K
Context Therapeutics Inc.
Shares:351.1K
Value:$214.9K